Literature DB >> 11704562

Upregulation of H(+)-peptide cotransporter PEPT2 in rat remnant kidney.

K Takahashi1, S Masuda, N Nakamura, H Saito, T Futami, T Doi, K Inui.   

Abstract

The progression of renal damage resulting from reduced nephron mass has been extensively studied in the 5/6 nephrectomized rat. However, reabsorption of small peptides and D-glucose across the renal proximal tubule in this model remains poorly understood. In this study, we examined the alterations of H(+)-peptide cotransporters (PEPT1 and PEPT2) and Na(+)-D-glucose cotransporters (SGLT1 and SGLT2) in chronic renal failure. Two weeks after surgery, H(+)-dependent [(14)C]glycylsarcosine uptake by the renal brush-border membrane vesicles isolated from 5/6 nephrectomized rats was significantly increased compared with that from sham-operated controls. Kinetic analysis revealed that the maximum velocity value for [(14)C]glycylsarcosine uptake by the high-affinity-type of peptide transporter was increased threefold by 5/6 nephrectomy, without significant changes in the apparent Michaelis-Menten constant value. Competitive PCR analyses indicated that the expression of PEPT2 mRNA was markedly increased in the remnant kidney, but PEPT1, SGLT1, and SGLT2 mRNA levels showed no significant changes. These findings indicated that the high-affinity-type H(+)-peptide cotransport activity is upregulated by 5/6 nephrectomy, accompanied by the increased expression of PEPT2. The upregulation of PEPT2 expression would result in an increase in reabsorption of small peptides and peptide-like drugs across the brush-border membranes in chronic renal failure.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11704562     DOI: 10.1152/ajprenal.0346.2000

Source DB:  PubMed          Journal:  Am J Physiol Renal Physiol        ISSN: 1522-1466


  10 in total

1.  Expression of Na+-D-glucose cotransporter SGLT2 in rodents is kidney-specific and exhibits sex and species differences.

Authors:  Ivan Sabolic; Ivana Vrhovac; Daniela Balen Eror; Maria Gerasimova; Michael Rose; Davorka Breljak; Marija Ljubojevic; Hrvoje Brzica; Anne Sebastiani; Serge C Thal; Christoph Sauvant; Helmut Kipp; Volker Vallon; Hermann Koepsell
Journal:  Am J Physiol Cell Physiol       Date:  2012-01-18       Impact factor: 4.249

2.  Evidence for extensive pleiotropy among pharmacogenes.

Authors:  Matthew T Oetjens; William S Bush; Joshua C Denny; Kelly Birdwell; Nuri Kodaman; Anurag Verma; Holli H Dilks; Sarah A Pendergrass; Marylyn D Ritchie; Dana C Crawford
Journal:  Pharmacogenomics       Date:  2016-06-01       Impact factor: 2.533

3.  Oligopeptide Transport in Rat Lung Alveolar Epithelial Cells is Mediated by Pept2.

Authors:  Hovhannes J Gukasyan; Tomomi Uchiyama; Kwang-Jin Kim; Carsten Ehrhardt; Sharon K Wu; Zea Borok; Edward D Crandall; Vincent H L Lee
Journal:  Pharm Res       Date:  2017-08-22       Impact factor: 4.200

4.  Urinary Concentration Defect and Renal Glycosuria in Cyclosporine-treated Rats.

Authors:  Jun Han Lee; Su A Kim; Chor Ho Jo; Chang Hwa Lee; Gheun-Ho Kim
Journal:  Electrolyte Blood Press       Date:  2020-06-18

Review 5.  Proton-coupled oligopeptide transporter family SLC15: physiological, pharmacological and pathological implications.

Authors:  David E Smith; Benjamin Clémençon; Matthias A Hediger
Journal:  Mol Aspects Med       Date:  2013 Apr-Jun

6.  Decreased activity and expression of intestinal oligopeptide transporter PEPT1 in rats with hyperthyroidism in vivo.

Authors:  Kayoko Ashida; Toshiya Katsura; Hideyuki Saito; Ken-ichi Inui
Journal:  Pharm Res       Date:  2004-06       Impact factor: 4.200

7.  Functional regulation of sugar assimilation by N-glycan-specific interaction of pancreatic α-amylase with glycoproteins of duodenal brush border membrane.

Authors:  Kimie Asanuma-Date; Yuki Hirano; Na Le; Kotone Sano; Nana Kawasaki; Noritaka Hashii; Yoko Hiruta; Ken-ichi Nakayama; Mariko Umemura; Kazuhiko Ishikawa; Hiromi Sakagami; Haruko Ogawa
Journal:  J Biol Chem       Date:  2012-05-14       Impact factor: 5.157

Review 8.  The proton oligopeptide cotransporter family SLC15 in physiology and pharmacology.

Authors:  Hannelore Daniel; Gabor Kottra
Journal:  Pflugers Arch       Date:  2003-08-07       Impact factor: 3.657

9.  Expression levels of renal organic anion transporters (OATs) and their correlation with anionic drug excretion in patients with renal diseases.

Authors:  Yuji Sakurai; Hideyuki Motohashi; Harumasa Ueo; Satohiro Masuda; Hideyuki Saito; Masahiro Okuda; Noriko Mori; Motokazu Matsuura; Toshio Doi; Atsushi Fukatsu; Osamu Ogawa; Ken-ichi Inui
Journal:  Pharm Res       Date:  2004-01       Impact factor: 4.200

10.  Evidence of an intestinal phosphate transporter alternative to type IIb sodium-dependent phosphate transporter in rats with chronic kidney disease.

Authors:  Yasuhiro Ichida; Shuichi Ohtomo; Tessai Yamamoto; Naoaki Murao; Yoshinori Tsuboi; Yoshiki Kawabe; Hiroko Segawa; Naoshi Horiba; Ken-Ichi Miyamoto; Jürgen Floege
Journal:  Nephrol Dial Transplant       Date:  2021-01-01       Impact factor: 5.992

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.